11130502 de C.H.-R., FONDECYT

regular N° 1131012 de M.A.-L. y

SA12I2197 de M.A.-L.

Recibido: 15 de septiembre de

Scarvajal@clinicasantamaria.cl Clostridium-difficile -associated diarrhoea and colitis. Lancet 1983; 2 (8358): 1043-6.

12.- Hernández-Rocha C, Naour S, Álvarez-Lobos M, Paredes-Sabja D. Clostridium difficile associated infections: an updated view. Rev Chilena Infectol 2012; 29: 434-45.

13.- Cohen S H, Gerding D N, Johnson S, Kelly C P, Loo V G, Mcdonald L C, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.

14.- Surawicz C M, Brandt L J, Binion D G, Ananthakrishnan A N, Curry S R, Gilligan P H, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108: 478-98; quiz 499.

15.- Debast S B, Bauer M P, Kuijper E J. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014; 20 Suppl 2: 1-26.

16.- Guyatt G H, Oxman A D, Kunz R, Falck-Ytter Y, Vist G E, Liberati A, et al. Going from evidence to recommendations. Br Med J 2008; 336: 1049-51.